Franklin Genomic Advancements ETF (HELX) Institutional Ownership $29.36 +2.20 (+8.11%) Closing price 11:51 AM EasternExtended Trading$29.36 +0.00 (+0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Institutional Ownership Changes (13F Filings) for Franklin Genomic Advancements ETF (BATS:HELX)Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$1.66MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$893.09K Get HELX Insider Trade Alerts Want to know when executives and insiders are buying or selling Franklin Genomic Advancements ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HELX Institutional Buying and Selling by Quarter Franklin Genomic Advancements ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Raymond James Financial Inc.1,500$42K0.0%N/A0.375% 5/19/2025 Jane Street Group LLC8,049$217K0.0%-80.4%2.012% 5/8/2025 Harbour Investments Inc.1,823$49K0.0%+1,240.4%0.456% 4/18/2025 Halbert Hargrove Global Advisors LLC2,554$69K0.0%+41.8%0.639% 2/17/2025 Citadel Advisors LLC7,966$230K0.0%N/A2.655% 2/14/2025 Jane Street Group LLC41,030$1.18M0.0%N/A13.677% 2/11/2025 LPL Financial LLC16,965$489K0.0%+19.5%5.655% 2/5/2025 Halbert Hargrove Global Advisors LLC1,801$52K0.0%N/A0.600% 7/31/2024 Commonwealth Equity Services LLC6,677$212K0.0%-5.2%2.226% 1/26/2023Vigilant Capital Management LLC900$27K0.0%N/A0.000% (Data available from 1/1/2016 forward) HELX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HELX shares? During the previous two years, the following institutional investors and hedge funds held shares of Franklin Genomic Advancements ETF shares: LPL Financial LLC ($489K), Citadel Advisors LLC ($230K), Jane Street Group LLC ($217K), Commonwealth Equity Services LLC ($212K), Halbert Hargrove Global Advisors LLC ($69K), and Harbour Investments Inc. ($49K), and Raymond James Financial Inc. ($42K).Learn more on Franklin Genomic Advancements ETF's institutional investors. Which institutional investors have been buying Franklin Genomic Advancements ETF's stock? The following institutional investors have purchased Franklin Genomic Advancements ETF's stock in the last 24 months: Jane Street Group LLC ($41.03K), Citadel Advisors LLC ($7.97K), LPL Financial LLC ($2.77K), Halbert Hargrove Global Advisors LLC ($2.55K), Harbour Investments Inc. ($1.69K), and Raymond James Financial Inc. ($1.50K). How much institutional buying is happening at Franklin Genomic Advancements ETF? Institutional investors have bought a total of 57,505 shares in the last 24 months. This purchase volume represents approximately $1.66M in transactions. Which of Franklin Genomic Advancements ETF's major shareholders have been selling company stock? The following institutional investors have sold Franklin Genomic Advancements ETF stock in the last 24 months: Jane Street Group LLC ($32.98K). How much institutional selling is happening at Franklin Genomic Advancements ETF? Institutional investors have sold a total of 32,981 shares in the last 24 months. This volume of shares sold represents approximately $893.09K in transactions. Related Companies NBCT Major Shareholders RBLD Major Shareholders WFH Major Shareholders JCHI Major Shareholders GRN Major Shareholders TOKE Major Shareholders SUPP Major Shareholders IVRA Major Shareholders MOTE Major Shareholders PSIL Major Shareholders This page (BATS:HELX) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access